k Glutamate transporter nanobody therapy, illustration Glutamate transporter nanobody therapy. Illustration of nanobodies acting as inhibitors of glutamate transport across a cell membrane. The figure shows a nanobody blue and white binding to a vesicular glutamate transporter VGLUT protein pink. The area of recognition between the two the epitope is highlighted in blue. This nanobody, when binding to the transporter protein, blocks its function which is the reuptake of the neurotransmitter glutamate in the neuronal synapses. This inhibition has potential use in treating a range of common neurological diseases. Stock Photo - Afloimages
Sign up
Login
All images
Glutamate transporter nanobody therapy, illustration Glutamate transporter nanobody therapy. Illustration of nanobodies acting as inhibitors of glutamate transport across a cell membrane. The figure shows a nanobody  blue and white  binding to a vesicular glutamate transporter  VGLUT  protein  pink . The area of recognition between the two  the epitope  is highlighted in blue. This nanobody, when binding to the transporter protein, blocks its function which is the re uptake of the neurotransmitter glutamate in the neuronal synapses. This inhibition has potential use in treating a range of common neurological diseases.
RM

Glutamate transporter nanobody therapy, illustration

Glutamate transporter nanobody therapy. Illustration of nanobodies acting as inhibitors of glutamate transport across a cell membrane. The figure shows a nanobody (blue and white) binding to a vesicular glutamate transporter (VGLUT) protein (pink). The area of recognition between the two (the epitope) is highlighted in blue. This nanobody, when binding to the transporter protein, blocks its function which is the re-uptake of the neurotransmitter glutamate in the neuronal synapses. This inhibition has potential use in treating a range of common neurological diseases.

Details

ID
170066996

Collection

License type
Rights Managed

Photographer



Sign in
Member access
Login not found.